EDGEMOND JAMES - Insider Transactions
Insider Type
individual
Companies
1
Average
878,139
Total Txns
59
Long-Term
Annual Transaction Insights
Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
---|---|---|---|---|---|---|
2024 | 0 | 50 | -50 | 0.00 | 43,995,800.17 | -43,995,800.17 |
2025 | 0 | 9 | -9 | 0.00 | 7,814,389.31 | -7,814,389.31 |
Total: | 0 | 59 | 10 | 0.00 | 51,810,189.48 | -51,810,189.48 |
Transactions
Company | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
United Therapeutics Corporation Common Stock US91307C1027 |
326.56 USD |
305 Sold |
99,602 USD |
09/06/2025 | 09/06/2025 |
United Therapeutics Corporation Common Stock US91307C1027 |
325.20 USD |
7,700 Sold |
2,504,068 USD |
09/06/2025 | 09/06/2025 |
United Therapeutics Corporation Common Stock US91307C1027 |
328.28 USD |
100 Sold |
32,828 USD |
09/06/2025 | 09/06/2025 |
United Therapeutics Corporation Common Stock US91307C1027 |
326.81 USD |
300 Sold |
98,042 USD |
09/06/2025 | 09/06/2025 |
United Therapeutics Corporation Common Stock US91307C1027 |
325.44 USD |
3,595 Sold |
1,169,955 USD |
09/06/2025 | 09/06/2025 |
United Therapeutics Corporation Common Stock US91307C1027 |
325.59 USD |
5,347 Sold |
1,740,929 USD |
02/06/2025 | 02/06/2025 |
United Therapeutics Corporation Common Stock US91307C1027 |
326.31 USD |
2,653 Sold |
865,688 USD |
02/06/2025 | 02/06/2025 |
United Therapeutics Corporation Common Stock US91307C1027 |
325.54 USD |
2,603 Sold |
847,380 USD |
02/06/2025 | 02/06/2025 |
United Therapeutics Corporation Common Stock US91307C1027 |
326.34 USD |
1,397 Sold |
455,896 USD |
02/06/2025 | 02/06/2025 |
United Therapeutics Corporation Common Stock US91307C1027 |
374.02 USD |
3,267 Sold |
1,221,923 USD |
04/11/2024 | 04/11/2024 |